(3R,5S,8R,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-3-[[4-(naphthalene-2-carbonyl)piperazin-1-yl]methyl]-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-one

ID: ALA4647998

PubChem CID: 156021305

Max Phase: Preclinical

Molecular Formula: C35H46N2O3

Molecular Weight: 542.76

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C[C@]12CC[C@](O)(CN3CCN(C(=O)c4ccc5ccccc5c4)CC3)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12

Standard InChI:  InChI=1S/C35H46N2O3/c1-33-15-16-35(40,22-27(33)9-10-28-29-11-12-31(38)34(29,2)14-13-30(28)33)23-36-17-19-37(20-18-36)32(39)26-8-7-24-5-3-4-6-25(24)21-26/h3-8,21,27-30,40H,9-20,22-23H2,1-2H3/t27-,28-,29-,30-,33-,34-,35+/m0/s1

Standard InChI Key:  DAAKIISCXNNJBB-IFEIANSXSA-N

Molfile:  

 
     RDKit          2D

 44 50  0  0  0  0  0  0  0  0999 V2000
   24.9818   -5.6573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6948   -5.2468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4079   -5.6573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4079   -6.4826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6948   -6.8932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9818   -6.4826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1539   -6.4826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7432   -7.1960    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.1539   -7.9094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7432   -8.6269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9176   -8.6269    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.5027   -7.9094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9176   -7.1960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5027   -9.3404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9176  -10.0536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7433  -10.0540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1513  -10.7649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7404  -11.4828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9206  -11.4851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5043  -10.7716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5084  -12.1990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9239  -12.9062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7420  -12.9013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1477  -12.1915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6812   -9.3404    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.5657   -7.1953    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.1210   -6.8932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8383   -6.4827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8383   -5.6574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1210   -5.2468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1210   -4.4215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8384   -4.0067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5515   -4.4215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5514   -5.2469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3356   -5.4988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8206   -4.8323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3357   -4.1654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5494   -3.3676    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.5514   -6.0683    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   28.5515   -3.5959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1210   -6.0683    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   27.8383   -4.8317    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   26.4079   -7.3082    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   26.4079   -4.8317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  6  5  1  0
  1  6  1  0
  6  7  1  1
  7  8  1  0
  9  8  1  0
 10  9  1  0
 11 10  1  0
 12 11  1  0
 13 12  1  0
  8 13  1  0
 11 14  1  0
 14 15  1  0
 16 15  2  0
 17 16  1  0
 18 17  2  0
 19 18  1  0
 20 19  2  0
 15 20  1  0
 19 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 18 24  1  0
 14 25  2  0
  6 26  1  0
  4 27  1  0
 28 27  1  0
 29 28  1  0
 30 29  1  0
  3 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 29 34  1  0
 34 35  1  0
 36 35  1  0
 37 36  1  0
 33 37  1  0
 37 38  2  0
 34 39  1  6
 33 40  1  1
 30 41  1  6
 29 42  1  1
  4 43  1  6
  3 44  1  1
M  END

Alternative Forms

  1. Parent:

    ALA4647998

    ---

Associated Targets(Human)

LAPC4 (305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 542.76Molecular Weight (Monoisotopic): 542.3508AlogP: 5.94#Rotatable Bonds: 3
Polar Surface Area: 60.85Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 7.53CX LogP: 5.63CX LogD: 5.26
Aromatic Rings: 2Heavy Atoms: 40QED Weighted: 0.52Np Likeness Score: 0.70

References

1. Boutin S, Roy J, Maltais R, Poirier D..  (2020)  Formation of 5α-dihydrotestosterone from 5α-androstane-3α,17β-diol in prostate cancer LAPC-4 cells - Identifying inhibitors of non-classical pathways producing the most potent androgen.,  30  (2): [PMID:31753699] [10.1016/j.bmcl.2019.126783]

Source